Adrenomedullin and endocrine disorders

Panminerva Medica

Volumn 45, Issue 4, 2003, Pages 241-251

  Letizia, C ^a,b   Rossi, G ^a   Cerci, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Adrenal gland hypofunction; Adrenomedullin; Cushing's syndrome; Diabetes mellitus; Hyperaldosteronism; Hyperparathyroidism; Hyperthyroidism; Insulinoma; Pheochromocytoma; Pre eclampsia; Pregnancy

Indexed keywords

ADRENOMEDULLIN; AMINO ACID; AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CORTICOSTEROID; CORTICOTROPIN; DISULFIDE; HORMONE; THYROID HORMONE; VASODILATOR AGENT;

ADDISON DISEASE; ADENOHYPOPHYSIS; ADRENAL CORTEX INSUFFICIENCY; ADRENAL GLAND; AMINO ACID COMPOSITION; AUTOCRINE EFFECT; BLOOD FLOW; BLOOD VESSEL; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR SYSTEM; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DIABETES MELLITUS; DISULFIDE BOND; DRUG ACTIVITY; DRUG EFFECT; ENDOCRINE DISEASE; GASTROINTESTINAL TRACT; HEART; HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; INSULINOMA; KIDNEY; KIDNEY FUNCTION; MENSTRUAL CYCLE; NEUROENDOCRINE SYSTEM; NONHUMAN; PANCREAS ISLET; PARACRINE SIGNALING; PEPTIDE SYNTHESIS; PHEOCHROMOCYTOMA; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIMARY HYPERALDOSTERONISM; PRIMARY HYPERPARATHYROIDISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION; TUMOR; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADRENOMEDULLIN; AMINO ACID SEQUENCE; CUSHING SYNDROME; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERPARATHYROIDISM; HYPERTHYROIDISM; INSULINOMA; MALE; MENSTRUAL CYCLE; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PARANEOPLASTIC ENDOCRINE SYNDROMES; PEPTIDES; PHEOCHROMOCYTOMA; PREGNANCY;

EID: 1542475766     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60.
2. Massart PE, Hodeige D, Donckie J. Adrenomedullin: view on a novel vasodilatatory peptide with natriuretic properties. Acta Cardiol 1996;51:259-69.
3. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001;22: 1693-71.
4. Nussdorfer GG, Rossi GP, Mazzocchi G. Role of adrenomedulin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 1997;18:1079-89.
5. Hisson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138-67.
6. Kangawa K, Kitamura K, Minamino N, Eto T, Matsuo H. Adrenomedullin: a new hypotensive peptide. J Hypertens 1996;14 Suppl:S105-10.
7. Washimine H, Asada Y, Kitamura K, Ichiki Y, Hara S, Yamamoto Y et al. Immunohistochemical identification of adrenomedullin in human, rat and porcine tissues. Histochemistry Cell Biol 1995; 103:251-4.
8. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, et al. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci Lett 1996;203:207-10.
9. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J et al. Endothelial cells actively synthetize and secrete adrenomedullin. Biochem Biophys Res Commun 1994;201:1160-6.
10. Samson WK, Murphy T, Schell DA. A novel vasoactive peptide, adrenomedullin, inhibits adrenocorticotropin release. Endocrinology 1995;136:2349-52.
11. Nishikimi T, Kitamura K, Saito Y, Shimada K, Ishimitsu T, Takamiya M et al. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994;24:600-4.
12. Yamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. Hypertension 1996;28:308-14.
13. Mazzocchi G, Rebuffat P, Gottardo G, Nussdorfer GG. Adrenomedullin and calcitonin gene-related peptide inhibit aldosterone secretion in rats, acting via a common receptor. Life Sci 1996;58:839-44.
14. Katoh F, Niina H, Kitamura K, Ichiki Y, Yamamoto Y, Kangawa K et al. Ca++-dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine cultured adrenal medullary cells. FEBS Lett 1994;348:61-4.
15. Katoh F, Kitamura K, Niina K, Yamamoto R, Washimine H, Kangawa K et al. Proadrenomedullin N-terminal 20 peptide (PAMP), on endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 1995;64: 459-61.
16. Kapas S, Martinez A, Cutitta F, Hinson JP. Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J Endocrinol 1998;156:477-84.
17. Nishikimi T, Kitamura K, Yoshihiko S, Shimada K, Ishimitsu T, Takamiya R et al. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994;24:600-4.
18. Letizia C, De Toma G, Caliumi C, Cerci S, Massa R, Loria RD et al. Plasma adrenomedullin concentrations in patients with adrenal pheochromocytoma. Horm Metab Res 2001;33:290-4.
19. Andreis PG, Neri G, Prayer-Galletti T, Rossi GP, Gottardo G, Malendowicz LK et al. Effect of adrenomedullin on the human adrenal glands, on in vivo study. J Clin Endocrinol Metab 1997;82:1167-70.
20. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M et al. Adrenomedullin in human brain, adrenal glands and tumour tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 1995;80:1750-2.
21. Minami J, Nishikimi T, Todoroki M, Kashiwakura C, Yagi H, Ono H et al. Source of plasma adrenomedullin in patients with pheochromocytoma. Am J Hypertens 2002;15:994-7.
22. Kato J, Kitamura K, Kuwasako K, Tanaka M, Ishiyama Y, Shimokubo T et al. Plasma adrenomedullin in patients with primary aldosteronism. Am J Hypertens 1995;8:997-1000.
23. Letizia C, De Toma G, Cerci S, Massa R, Coassin S, Subioli S et al. Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure. Blood Press 1998;7:19-23.
24. Vari RC, Adkins SD, Samson WK. Renal effects of adrenomedullin in the rat. Proc Soc Exp Biol Med 1996;211:178-83.
25. Letizia C, Cerci S, Centanni M, De Toma G, Subioli S, Scuro L et al. Circulating levels of adrenomedullin in patients with Addison's disease before and after corticosteroid treatment. Clin Endocrinol 1998;48:145-8.
26. Minamino N, Shoji H, Sugo S, Kangawa K, Matsuo H. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995;211:686-93.
27. Taniyama M, Kitamura K, Ban Y, Digita E, Ito K, Katagiri T. Elevation of proadrenomedullin N-20 terminal peptide in thyrotoxicosis. Clin Endocrinol 1997;47:271-4.
28. Diekman MJN, Harms MPM, Endert E, Weiling W, Wiersinga WM. Endocrine factors releted to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. Eur J Endocrinol 2001;144:339-46.
29. Taniyama M, Kitamira K, Ban Y, Eto T, Kitagiri T. Elevated plasma adrenomedullin levels in hyperthyroidism. Eur J Clin Invest 1996;26:254-6.
30. Letizia C, Caliumi C, Delfini E, Celi M, Subioli S, Diacinti D et al. Adrenomedullin concentrations are elevated in plasma of patients with primary hyperparathyroidism. Metabolism 2003;52:159-62.
31. Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1986;4:360-70.
32. Scholtz DA. Hypertension and hyperparathyroidism. Arch Intern Med 1977;137:1123-4.
33. Ghose RR, Morgan WD. Improvement of renal function in primary hyperparathyroidism following parathyroidectomy. Postgrad Med J 1981;57:28-30.
34. Letizia C, Delfini E, De Toma G, Caliumi C, Minisola S, Diacinti D et al. Renin-angiotensin-aldosterone and endothelin-1 system in primary hyperparathyroidism associated with arterial hypertension. Ital J Mineral Electrolyte Metab 2001;15:21-6.
35. Murakami O, Takahashi K, Satoh F, Totsune K, Sone M, Arihara Z et al. Expression of adrenomedullin and adrenomedullin mRNA in ectopic ACTH-secreting tumors. Eur J Endocrinol 1998;138:436-9.
36. Mazzocchi G, Musajo FG, Neri G, Gottardo G, Nussdorfer GG. Adrenomedullin stimulates steroid secretion by the isolated perfused rat adrenal gland in situ. Comparison with calcitonin gene-related peptide effects. Peptides 1998;17:853-7.
37. Letizia C, Di Iorio R, De Toma G, Marinoni E, Cerci S, Celi M et al. Circulating adrenomedullin is increased in patients with corticotropin- dependent Cushing syndrome due to pituitary adenoma. Metabolism 2000;49:760-3.
38. Parkes DG, May CN. ACTH-suppression and vasodilatator actions of adrenomedullin in conscious sheep. J Neuroendocrinol 1995;7: 923-6.
39. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994;93:2158-61.
40. Garcia-Unzueta MT, Berrazueta JR, Montalban C, Pesquera C, Berrazueta JR, Amado JA. Plasma adrenomedullin levels in type 1 diabetes. Diabetes Care 1998;21:999-1003.
41. Hirata Y, Hayakawa H, Suzuki Y, Suzuki E, Ikenouchi H, Kohmoto O et al. Mechanism of adrenomedullin-induced vasodilatation in the rat kidney. Hypertension 1995;25:790-5.
42. Kinoshita H, Kato K. Plasma adrenomedullin levels in patients with diabetes. Diabetes Care 2000;23:253-7.
43. Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, Fujita T. Plasma adrenomedullin in diabetes. Lancet 1997;350:1449-50.
44. Letizia C, Balducci S, Petramala L, Cotesta D, Vingolo EM, Fallucca F et al. Plasma levels of adrenomedullin, a newly identified peptide, in type 2 diabetic patients with and without retinopathy. J Endocrinol Invest 2003 (Suppl. 6).
45. Martinez A, Weaver C, Lopez J, Bhathena SJ, Elsasser TH, Miller MJ et al. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 1996;137:2626-32.
46. Letizia C, Tamburrano G, Alò P, Paoloni A, Caliumi C, Marinoni E et al. Adrenomedullin, a new peptide, in patients with insulinoma. Eur J Endocrinol 2001;144:517-20.
47. Mulder H, Ahren R, Karlsson S, Sundler F. Adrenomedullin: localization in the gastrointestinal tract and effect on insulin secretion. Regul Pept 1996;62:107-12.
48. Elhenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. Circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes 1997;105:156-62.
49. Marinoni E, Di Iorio R, Letizia C, Villaccio B, Scucchi L, Cosmi EV. Immunoreactive adrenomedullin in human fetoplacentar tissues. Am J Obstet Gynecol 1998;179:784-7.
50. Di Iorio R, Marinoni E, Letizia C, Villaccio B, Alberini A, Cosmi EV. Adrenomedullin production is increased in normal human pregnancy. Eur J Endocrinol 1999;140:201-6.
51. Di Iorio R, Marinoni E, Scavo D, Letizia C, Cosmi EV. Adrenomedullin in pregnancy. Lancet 1997;349:328.
52. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial studies of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989;256:H1060-5.
53. Macrì CJ, Martinez A, Moody TW, Gray KD, Miller MJ, Gallagher M et al. Detection of adrenomedullin, a hypotensive peptide, in amniotic fuid and fetal membranes. Am J Obstet Gynecol 1996;175:906-11.
54. Withers DJ, Coppock HA, Seufferlein T, Smith DM, Bloom SR, Rozengurt E. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of camp in Swiss 373 cells. FEBS Lett 1996;378:83-7.
55. Miura K, Ebara T, Okumura M, Matsuura T, Kim S, Yukimura T et al. Attenuation of adrenomedullin-induced renal vasodilatation by Ng-nitro L-arginine but not glibenclamide. Br J Pharmacol 1995;115:917-24.
56. Kohno M, Kano H, Horio T, Yokokawa K, Yasunari K, Takeda T. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension 1995;25:1885-90.
57. Marinoni E, Di Iorio R, Letizia C, Lucchini C, Alo P, Cosmi EV. Changes in plasma adrenomedullin levels during the mestrual cycle. Regul Pept 2000;87:15-8.
58. Kapas S, Cat RJ, Clark AJL. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 1995;270:25344-7.
59. Zhao Y, Hagne S, Manek S, Zhang L, Bicknell R, Rees MC. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 1998;16:409-15.
60. Oian P, Tollan A, Fadnes HO, Noddeland H, Maltau JM. Transcapillary fluid dynamics during menstrual cycle. Am Gynecol 1987;156:952-5.
61. Roberts JM, Redman CWG. Pre-eclampsica: more than pregnancy-induced hypertension. Lancet 1993;341:1447-51.
62. Di Iorio R, Marinoni E, Coacci F, La Torre R, Cosmi EV. Amniotic fluid nitric oxide and uteroplacental blood flow in pregnancy complicated by intrauterine growth retardation. Br J Obstet Gynecol 1997;104:1134-9.
63. Marinoni E, Picca A, Scucchi L, Cosmi EV, Di Iorio R. Immunohistochemical localization of endothelin-1 in placenta and fetal membranes in term and preterm human pregnancy. Am J Report Immunol 1995;34:213-8.
64. Di Iorio R, Marinoni E, Letizia C, Alo P, Villaccio B, Cosmi EV. Adrenomedullin, a new vasoactive peptide is increased in preeclampsia. Hypertension 1998;32:758-63.
65. Marinoni E, Picca A, Scucchi L, Cosmi EV, Di Iorio R. Immuno-histochemical localization of endothelin-1 in placenta and fetal membranes in term and preterm human pregnancy. Am J Reprod Immunol 1995;34:213-8.